Zhonghong Pulin Medical Products Co. Ltd. (300981) — Working Capital to Net Assets Ratio
Zhonghong Pulin Medical Products Co. Ltd. (300981) has a Working Capital to Net Assets ratio of 60.4% as of September 2025. Working capital of CN¥3.33 Billion (current assets of CN¥4.86 Billion minus current liabilities of CN¥1.53 Billion) is measured against net assets of CN¥5.51 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See 300981 days of operational coverage to measure how many days the company can operate on defensive assets alone.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Zhonghong Pulin Medical Products Co. Ltd. Working Capital to Net Assets (2013–2024)
This chart shows how Zhonghong Pulin Medical Products Co. Ltd.'s Working Capital to Net Assets ratio has evolved across 12 annual periods from 2013 to 2024. As of September 2025, the ratio stands at 60.4%, reflecting working capital of CN¥3.33 Billion against net assets of CN¥5.51 Billion CNY. For the complete balance sheet picture, see 300981 total assets.
Annual Working Capital to Net Assets for Zhonghong Pulin Medical Products Co. Ltd. (2013–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for Zhonghong Pulin Medical Products Co. Ltd. from 2013 to 2024, covering 12 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Check Zhonghong Pulin Medical Products Co. Ltd (300981) liquid assets ratio to evaluate the company's liquid asset resilience ratio.
| Year | WC/NA Ratio | Working Capital (CNY) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 59.3% | CN¥3.33 Billion | CN¥5.62 Billion | CN¥4.57 Billion | CN¥1.24 Billion | ▲ +4.8 pp |
| 2023 | 54.6% | CN¥3.23 Billion | CN¥5.92 Billion | CN¥4.00 Billion | CN¥770.16 Million | ▼ -7.5 pp |
| 2022 | 62.0% | CN¥3.80 Billion | CN¥6.13 Billion | CN¥4.45 Billion | CN¥644.17 Million | ▼ -8.8 pp |
| 2021 | 70.8% | CN¥4.64 Billion | CN¥6.55 Billion | CN¥5.21 Billion | CN¥565.03 Million | ▲ +9.7 pp |
| 2020 | 61.1% | CN¥1.56 Billion | CN¥2.56 Billion | CN¥2.66 Billion | CN¥1.10 Billion | ▲ +75.9 pp |
| 2019 | -14.8% | CN¥-69.07 Million | CN¥467.67 Million | CN¥437.18 Million | CN¥506.25 Million | ▲ +17.1 pp |
| 2018 | -31.9% | CN¥-119.84 Million | CN¥376.10 Million | CN¥409.46 Million | CN¥529.30 Million | ▼ -33.0 pp |
| 2017 | 1.2% | CN¥3.79 Million | CN¥319.89 Million | CN¥332.32 Million | CN¥328.53 Million | ▲ +8.8 pp |
| 2016 | -7.7% | CN¥-19.56 Million | CN¥255.25 Million | CN¥297.64 Million | CN¥317.20 Million | ▲ +19.4 pp |
| 2015 | -27.0% | CN¥-51.80 Million | CN¥191.49 Million | CN¥250.49 Million | CN¥302.29 Million | ▲ +12.1 pp |
| 2014 | -39.2% | CN¥-59.31 Million | CN¥151.32 Million | CN¥278.23 Million | CN¥337.54 Million | ▲ +28.5 pp |
| 2013 | -67.7% | CN¥-84.93 Million | CN¥125.53 Million | CN¥284.45 Million | CN¥369.38 Million | — |